Join
Live feed
·
INSIDERFilingvia Quantisnow
Cabaletta Bio Inc. logo

Director Bollard Catherine bought $9,982 worth of shares (4,405 units at $2.27), increasing direct ownership by 440% to 5,405 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
CABA· Cabaletta Bio Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CABA (Cabaletta Bio Inc.) and more on Quantisnow.